What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary scientific interests are in Immunology, Arthritis, Internal medicine, Inflammation and Rheumatoid arthritis.
Immunology is frequently linked to Bone resorption in his study.
His research integrates issues of Cortical bone, Bone marrow, Pathology and Osteoclast in his study of Arthritis.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Surgery.
His Inflammation study combines topics from a wide range of disciplines, such as Phagocytosis, Immune system and Pathogenesis.
His Rheumatoid arthritis research includes elements of Gastroenterology, Connective tissue disease and Disease.
His most cited work include:
- The pathogenesis of rheumatoid arthritis. (2868 citations)
- Cytokines in the pathogenesis of rheumatoid arthritis (1789 citations)
- Dickkopf-1 is a master regulator of joint remodeling (1019 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Immunology, Rheumatoid arthritis, Arthritis and Inflammation.
His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His research in Rheumatoid arthritis intersects with topics in Quantitative computed tomography, Disease, Pathology, Connective tissue disease and Physical therapy.
He interconnects Surgery, Cancer research and Cartilage in the investigation of issues within Arthritis.
His Inflammation research integrates issues from Tumor necrosis factor alpha and Osteoclast.
His work focuses on many connections between Osteoclast and other disciplines, such as Bone remodeling, that overlap with his field of interest in Bone resorption.
He most often published in these fields:
- Internal medicine (34.82%)
- Immunology (30.73%)
- Rheumatoid arthritis (23.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (34.82%)
- Rheumatoid arthritis (23.00%)
- Arthritis (22.44%)
In recent papers he was focusing on the following fields of study:
Georg Schett spends much of his time researching Internal medicine, Rheumatoid arthritis, Arthritis, Immunology and Psoriatic arthritis.
The Rheumatology and Disease research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
Georg Schett studies Rheumatoid arthritis, focusing on Rheumatoid factor in particular.
His studies deal with areas such as Tumor necrosis factor alpha, Endocrinology, Bone remodeling and RANKL as well as Arthritis.
Immune system, Inflammation, Autoimmunity, Cytokine and Autoantibody are among the areas of Immunology where he concentrates his study.
His work in Inflammation tackles topics such as Cell biology which are related to areas like Osteoclast, Chromatin and Fibrosis.
Between 2018 and 2021, his most popular works were:
- COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (167 citations)
- To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps. (124 citations)
- Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. (111 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Georg Schett mostly deals with Inflammation, Immunology, Arthritis, Internal medicine and Rheumatoid arthritis.
His studies in Inflammation integrate themes in fields like Osteoclast, Innate lymphoid cell, Cytokine and Cell biology.
His biological study spans a wide range of topics, including Disease and Eosinophilic.
His work carried out in the field of Arthritis brings together such families of science as Tumor necrosis factor alpha, Autoimmune disease, Macrophage and Peripheral blood mononuclear cell.
The various areas that Georg Schett examines in his Internal medicine study include Gastroenterology and Placebo.
His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Eosinophil, Clinical trial, Interleukin 6, Autoantibody and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
